CA
GMED icon

CastleArk Alternatives’s Globus Medical GMED Stock Holding History

CastleArk Alternatives’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,590
Closed -$1.42M – 122
2021
Q3 		$1.42M Buy
+18,590
New +$1.49M 0.05% 208

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

CastleArk Alternatives's GMED Position: Q4 2021 in Review

CastleArk Alternatives sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 18,590 shares — an estimated $1.42M sold.

CastleArk Alternatives first reported a position in GMED in Q3 2021 and held it in 1 quarter. The position peaked at $1.42M in Q3 2021. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

  • CastleArk Alternatives reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
  • CastleArk Alternatives sold 18,590 Globus Medical shares in Q4 2021, an estimated $1.42M.
  • CastleArk Alternatives first reported a position in Globus Medical in Q3 2021 and held it in 1 quarter.
  • CastleArk Alternatives's Globus Medical position peaked at $1.42M in Q3 2021.
  • 373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.